The rising prevalence of cardiovascular diseases (CVDs), including conditions like Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD), is significantly propelling the demand for balloon catheters, particularly in angioplasty procedures. CVDs have become a leading cause of death globally, with lifestyle changes such as increased consumption of high-fat diets, smoking, physical inactivity, and stress contributing to their growing incidence. As populations continue to age and life expectancy rises, the prevalence of these diseases is expected to surge, creating a growing need for effective treatment methods.
Balloon catheters, which are widely used in angioplasty, play a crucial role in opening up blocked or narrowed arteries, allowing improved blood flow to the heart and other vital organs. In procedures like percutaneous coronary intervention (PCI), balloon catheters are used to dilate the coronary arteries, reducing the risk of heart attacks and other complications associated with coronary artery blockages. Similarly, in the case of PAD, which affects blood flow to the limbs, balloon catheters help restore circulation, preventing limb loss and enhancing patient outcomes.
Access Full Report @ https://www.databridgemarketresearch.com/de/reports/global-balloon-catheter-market
Data Bridge Market Research analyses that the Global Balloon Catheter Market is expected to reach USD 6.88 billion by 2031 from USD 4.30 billion in 2023, growing with a CAGR of 6.1% in the forecast period of 2024 to 2031.
Key Findings of the Study
Increasing Geriatric Population
The growing geriatric population is emerging as a significant driver of the global balloon catheter market, primarily due to the heightened vulnerability of older adults to chronic diseases, particularly cardiovascular conditions. As life expectancy increases globally, more people are living into their 60s and beyond, and with this comes an elevated incidence of age-related health issues such as coronary artery disease (CAD), peripheral artery disease (PAD), and heart failure. These conditions often require timely medical intervention to prevent serious complications such as heart attacks or strokes, which are more prevalent among the elderly.
Minimally invasive procedures, such as angioplasty, which use balloon catheters to dilate narrowed or blocked arteries, have become the preferred treatment for managing cardiovascular diseases in elderly patients. These procedures offer several advantages for older adults, including reduced risk compared to traditional open-heart surgeries, shorter recovery times, and fewer post-operative complications. Given that many geriatric patients have coexisting medical conditions, the less invasive nature of angioplasty makes it an ideal solution for restoring arterial blood flow while minimizing the physical stress on the body. As a result, balloon catheters, which are essential in these procedures, are seeing increased demand in healthcare systems globally.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Year
|
2022 (Customizable to 2016 – 2021)
|
|
Quantitative Units
|
Revenue in USD Billion
|
|
Segments Covered
|
Type (PTCA Balloon Catheters, CTO Balloon Catheters, and Microcatheters), Product Type (Normal Balloon Catheter, Drug Eluting Balloon Catheter, Cutting Balloon Catheter, Stent Graft Balloon Catheter, and Scoring Balloon Catheter), Delivery Platform (Rapid Exchange (RX) / Monorail Balloon Catheter, Over-The-Wire (OTW), and Fixed Wire (FW) Balloon Catheter), Compliance (Non-Compliant, Semi-Compliant, and Compliant), Balloon Material (Nylon, Polyethylene Terephthalate (PET), Polyethylene (PE), Silicone, Polyolefin Copolymer, and Others), Balloon Type (High-Pressure Balloons and Elastomeric Balloons), Application (Coronary Artery Disease, Peripheral Artery Disease, and Others), End User (Hospitals, Specialty Centers, Ambulatory Surgery Centers, and Others), Distribution Channel (Direct Tender, Third Party Distribution, and Others)
|
|
Market Players Covered
|
Boston Scientific Corporation (U.S.), Medtronic (U.S.), Abbott (U.S.), Terumo Corporation (Japan), BD (U.S.), B. Braun SE (Germany), Koninklijke Philips N.V. (Netherlands), Teleflex Incorporated (U.S.), Cook (U.S.), Lepu Medical Technology (Beijing) Co., Ltd. (China), KANEKA CORPORATION (Japan), MicroPort Scientific Corporation (China), Acrostak Int. Distr. Sàrl (Switzerland), Biotronik (Germany), Alvimedica (Turkey), SMT (India), BALTON (Poland), APR Medtech Ltd (England), Advin Health Care (India) among others
|
|
Countries Covered
|
U.S., Canada, and Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Netherlands, Belgium, Switzerland, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Indonesia, Thailand, Malaysia, Vietnam, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Peru, and Rest of South America, South Africa, Saudi Arabia, U.A.E., Israel, Egypt, Morocco, Kuwait, and Rest of Middle East and Africa
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis
The global balloon catheter market is segmented into nine notable segments based on type, product type, delivery platform, compliance, balloon material, balloon type, application, end user, and distribution channel.
- On the basis of type, the market is segmented into PTCA balloon catheters, CTO balloon catheters, and microcatheters
In 2024, the PTCA balloon catheters segment is expected to dominate the global balloon catheter market
In 2024, The PTCA balloon catheters segment is expected to dominate the market with market share of 65.53%, due to their widespread use in percutaneous coronary interventions (PCI) for treating coronary artery disease.
- On the basis of product type, the market is segmented into normal balloon catheter, drug eluting balloon catheter, cutting balloon catheter, stent graft balloon catheter, and scoring balloon catheter
In 2024, the normal balloon catheter segment is expected to dominate the global balloon catheter market
In 2024, the normal balloon catheter segment is expected to dominate the market with a market share of 54.30% because growing geriatric population.
- On the basis of delivery platform, the market is segmented into Rapid Exchange (RX) / monorail balloon catheter, Over-The-Wire (OTW), and Fixed Wire (FW) balloon catheter. In 2024, Rapid Exchange (RX) / monorail balloon catheter segment is expected to dominate the market with a market share of 68.31%
- On the basis of compliance, the market is segmented into non-compliant, semi-compliant and compliant. In 2024, the non-compliant segment is expected to dominate the market with a market share of 57.34%
- On the basis of balloon material, the market is segmented into nylon, Polyethylene Terephthalate (PET), Polyethylene (PE), silicone, polyolefin copolymer, and others. In 2024, the nylon segment is expected to dominate the market with a market share of 38.55%
- On the basis of balloon type, the market is segmented into high-pressure balloons and elastomeric balloons. In 2024, the high-pressure balloons segment is expected to dominate the market with a market share of 63.57%
- On the basis of application, the market is segmented into coronary artery disease, peripheral artery disease, and others. In 2024, the coronary artery disease segment is expected to dominate the market with a market share of 55.36%
- On the basis of end user, the market is segmented into hospitals, specialty centers, ambulatory surgery centers, and others. In 2024, the hospitals segment is expected to dominate the market with a market share of 67.27%
- On the basis of distribution channel, the market is segmented into direct tender, third party distribution, and others. In 2024, the direct tender segment is expected to dominate the market with a market share of 50.54%
Major Players
Data Bridge Market Research analyses Boston Scientific Corporation (U.S.), Medtronic (U.S.), ABBOTT LABORATORIES (U.S.), TERUMO MEDICAL CORPORATION (Japan), C.R. BARD, INC. (BD) (U.S.) as major market players in this market.
Market Development
- In November 2023, Boston Scientific concluded its acquisition of Relievant Medsystems, adding the Intracept Intraosseous Nerve Ablation System to its chronic pain portfolio. The acquisition, costing USD 850 million upfront plus contingent payments, expands access to vertebrogenic pain treatment through national coverage, benefiting over 150 million lives
- In April 2023, Abbott completed its acquisition of Cardiovascular Systems, Inc., a company known for its innovative atherectomy system used in treating vascular disease. CSI's system, which prepares vessels for angioplasty or stenting, became part of Abbott’s vascular portfolio. CSI shares ceased trading on Nasdaq that day
- In August 2022, Boston Scientific announced the acquisition of Obsidio, Inc., a company behind the GEM technology for embolization in peripheral vasculature. The semi-solid GEM material, recently FDA-cleared, simplifies embolization procedures with its unique gel-like properties. The transaction was not expected to affect Boston Scientific's 2022 earnings materially
- In February 2022, Medtronic received FDA approval for its Freezor and Freezor Xtra catheters to treat pediatric atrioventricular nodal reentrant tachycardia (AVRNT). This cryoablation therapy, is effective for over 140,000 patients worldwide, targets abnormal heart rhythms in children, helping to prevent life-threatening complications and support normal heart function
Geographically, the countries covered in this market report are U.S., Canada, and Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Netherlands, Belgium, Switzerland, Austria, Norway, Hungary, Lithuania, Ireland, Poland, rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Indonesia, Thailand, Malaysia, Vietnam, Philippines, rest of Asia-Pacific, Brazil, Argentina, Peru, and rest of South America, South Africa, Saudi Arabia, U.A.E., Israel, Egypt, Morocco, Kuwait, and rest of Middle East and Africa.
North America is expected to dominated the global balloon catheter market
North America is expected to dominate the market because prevalence of cardiovascular diseases (CVDs).
Asia-Pacific is expected to be fastest growing region in the global balloon catheter market
Asia-Pacific is expected to fastest growing region in the market because increase in healthcare expenditure.
For more detailed information about the global balloon catheter market report, click here – https://www.databridgemarketresearch.com/de/reports/global-balloon-catheter-market
